Last Updated: 06 Jun 2025
Source: Statifacts
The U.S. water for injection market size surpassed USD 10.78 billion in 2024 and is predicted to reach around USD 27.92 billion by 2034, registering a CAGR of 9.98% from 2025 to 2034.
Industry Worth | Details |
Market Size in 2025 | USD 12 Billion |
Market Size by 2034 | USD 27.92 Billion |
Market Growth Rate from 2025 to 2034 | CAGR of 9.98% |
Water for injection is water of the utmost purity that has applications in the preparation of drugs for injection and various other intravenous therapeutics. The growing demand for injectable pharmaceutical products such as vaccines, insulin, monoclonal antibodies, and biologics is fueling the market for water for injection. The increasing number of chronic disease patients, coupled with the shift toward biologic therapies, supports the demand for water for injection. Every global health authority mandates the use of ultra-pure, often distilled water during sterile drug production, followed by the use of cutting-edge technologies in water for injection production, which include multiple-effect distillation, vapour compression, and advanced membrane-based reverse osmosis systems.
Improvements in production systems, with a focus on process reliability, quality assurance, and energy efficiency, are hence driving new water purification systems that achieve both quality and green objectives, greatly benefitting the U.S. water for injection market. Finally, considering the wave of injected therapies and the global expansion of drug manufacturing, it is clear to stay that water for injection will feature very prominently within pharmaceutical production towns.
Published by Kesiya Chacko
The market is valued at over US$ 12 billion and is expected to grow steadily.
Technological advancements, rising AI adoption, and R&D projects drive market growth.
The formulated parental drugs & pharmaceutical, and biotechnology segment dominates the water for injection market.
Stats ID: | 8381 |
Format: | Databook |
Published: | June 2025 |
Delivery: | Immediate |
Last Updated: 06 Jun 2025
Source: Statifacts
Last Updated: 06 Jun 2025
Source: Statifacts
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical and Biotechnology Companies | 4.66 | 5.18 | 5.76 | 6.38 | 7.04 | 7.76 | 8.53 | 9.36 | 10.23 | 11.17 | 12.07 |
Research Institutes | 3.97 | 4.42 | 4.91 | 5.43 | 6.00 | 6.62 | 7.27 | 7.98 | 8.73 | 9.53 | 10.29 |
Others | 2.15 | 2.40 | 2.66 | 2.95 | 3.25 | 3.58 | 3.94 | 4.32 | 4.72 | 5.15 | 5.56 |
Last Updated: 06 Jun 2025
Source: Statifacts
Stats ID: | 8381 |
Format: | Databook |
Published: | June 2025 |
Delivery: | Immediate |
To get full access to our Market Insights, you need a Professional Account or a Business Suite.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Our customers work more efficiently and benefit from